1 Min Read
Oct 10 (Reuters) - Akcea Therapeutics:
* Akcea Therapeutics Inc says UK announced that Volanesorsen has been granted a PIM designation by MHRA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.